Annual EBITDA
-$9.86 M
+$17.97 M+64.57%
November 30, 2023
Summary
- As of February 8, 2025, THTX annual EBITDA is -$9.86 million, with the most recent change of +$17.97 million (+64.57%) on November 30, 2023.
- During the last 3 years, THTX annual EBITDA has fallen by -$1.09 million (-12.44%).
- THTX annual EBITDA is now -205.70% below its all-time high of $9.33 million, reached on November 30, 2010.
Performance
THTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$7.00 M
+$1.94 M+38.23%
August 31, 2024
Summary
- As of February 8, 2025, THTX quarterly EBITDA is $7.00 million, with the most recent change of +$1.94 million (+38.23%) on August 31, 2024.
- Over the past year, THTX quarterly EBITDA has increased by +$4.00 million (+133.86%).
- THTX quarterly EBITDA is now -65.86% below its all-time high of $20.49 million, reached on November 30, 2010.
Performance
THTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$11.56 M
+$4.00 M+52.98%
August 31, 2024
Summary
- As of February 8, 2025, THTX TTM EBITDA is $11.56 million, with the most recent change of +$4.00 million (+52.98%) on August 31, 2024.
- Over the past year, THTX TTM EBITDA has increased by +$26.74 million (+176.20%).
- THTX TTM EBITDA is now at all-time high.
Performance
THTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
THTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.6% | +133.9% | +176.2% |
| 3 y3 years | -12.4% | +198.7% | +139.3% |
| 5 y5 years | -1351.3% | +198.7% | +139.3% |
THTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.6% | at high | +154.9% | at high | +138.1% |
| 5 y | 5-year | <-9999.0% | +64.6% | at high | +154.9% | at high | +138.1% |
| alltime | all time | -205.7% | +72.9% | -65.9% | +154.9% | at high | +125.6% |
Theratechnologies EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2024 | - | $7.00 M(+38.2%) | $11.56 M(+53.0%) |
| May 2024 | - | $5.06 M(-519.7%) | $7.56 M(-290.2%) |
| Feb 2024 | - | -$1.21 M(-269.6%) | -$3.98 M(-59.7%) |
| Nov 2023 | -$9.86 M(-64.6%) | $711.00 K(-76.2%) | -$9.86 M(-35.0%) |
| Aug 2023 | - | $2.99 M(-146.2%) | -$15.18 M(-34.4%) |
| May 2023 | - | -$6.47 M(-8.7%) | -$23.15 M(-21.3%) |
| Feb 2023 | - | -$7.09 M(+54.0%) | -$29.41 M(+5.7%) |
| Nov 2022 | -$27.83 M(+61.3%) | -$4.60 M(-7.6%) | -$27.83 M(-5.8%) |
| Aug 2022 | - | -$4.98 M(-60.9%) | -$29.53 M(-2.8%) |
| May 2022 | - | -$12.74 M(+131.5%) | -$30.39 M(+49.0%) |
| Feb 2022 | - | -$5.50 M(-12.8%) | -$20.40 M(+18.3%) |
| Nov 2021 | -$17.25 M(+96.7%) | -$6.31 M(+8.0%) | -$17.25 M(+33.6%) |
| Aug 2021 | - | -$5.84 M(+112.8%) | -$12.91 M(+25.1%) |
| May 2021 | - | -$2.75 M(+17.0%) | -$10.32 M(+4.2%) |
| Feb 2021 | - | -$2.35 M(+19.2%) | -$9.91 M(+13.0%) |
| Nov 2020 | -$8.77 M(>+9900.0%) | -$1.97 M(-39.5%) | -$8.77 M(-12.8%) |
| Aug 2020 | - | -$3.26 M(+39.5%) | -$10.06 M(+92.0%) |
| May 2020 | - | -$2.33 M(+92.9%) | -$5.24 M(+82.2%) |
| Feb 2020 | - | -$1.21 M(-62.9%) | -$2.88 M(>+9900.0%) |
| Nov 2019 | -$11.00 K(-101.4%) | -$3.26 M(-308.4%) | -$11.00 K(-100.2%) |
| Aug 2019 | - | $1.56 M(+5116.7%) | $5.17 M(-1.8%) |
| May 2019 | - | $30.00 K(-98.2%) | $5.26 M(+34.0%) |
| Feb 2019 | - | $1.66 M(-13.6%) | $3.92 M(+398.1%) |
| Nov 2018 | $788.00 K(-106.7%) | $1.92 M(+15.5%) | $788.00 K(-121.7%) |
| Aug 2018 | - | $1.66 M(-227.2%) | -$3.64 M(-47.8%) |
| May 2018 | - | -$1.30 M(-12.1%) | -$6.96 M(-40.8%) |
| Feb 2018 | - | -$1.48 M(-40.9%) | -$11.75 M(+4.3%) |
| Nov 2017 | -$11.72 M(-409.6%) | -$2.51 M(+50.7%) | -$11.27 M(+50.8%) |
| Aug 2017 | - | -$1.67 M(-72.7%) | -$7.47 M(+68.4%) |
| May 2017 | - | -$6.09 M(+508.5%) | -$4.44 M(-316.8%) |
| Feb 2017 | - | -$1.00 M(-177.7%) | $2.05 M(-45.6%) |
| Nov 2016 | $3.79 M(-22.8%) | $1.29 M(-5.9%) | $3.76 M(-7.7%) |
| Aug 2016 | - | $1.37 M(+252.4%) | $4.08 M(-8.6%) |
| May 2016 | - | $388.70 K(-45.6%) | $4.46 M(-20.6%) |
| Feb 2016 | - | $715.10 K(-55.4%) | $5.62 M(+12.2%) |
| Nov 2015 | $4.90 M(-168.8%) | $1.60 M(-8.5%) | $5.00 M(+252.2%) |
| Aug 2015 | - | $1.75 M(+13.2%) | $1.42 M(-140.8%) |
| May 2015 | - | $1.55 M(+1400.8%) | -$3.49 M(-8.1%) |
| Feb 2015 | - | $103.10 K(-105.2%) | -$3.79 M(-46.7%) |
| Nov 2014 | -$7.13 M(+93.7%) | -$1.98 M(-37.2%) | -$7.12 M(-5.7%) |
| Aug 2014 | - | -$3.16 M(-354.3%) | -$7.55 M(+21.9%) |
| May 2014 | - | $1.24 M(-138.5%) | -$6.19 M(-29.1%) |
| Feb 2014 | - | -$3.22 M(+33.5%) | -$8.74 M(+141.5%) |
| Nov 2013 | -$3.68 M(+2.1%) | -$2.41 M(+33.9%) | -$3.62 M(+310.5%) |
| Aug 2013 | - | -$1.80 M(+38.6%) | -$881.30 K(-1145.4%) |
| May 2013 | - | -$1.30 M(-168.5%) | $84.30 K(-20.8%) |
| Feb 2013 | - | $1.90 M(+486.7%) | $106.40 K(-103.1%) |
| Nov 2012 | -$3.60 M(-79.0%) | $323.30 K(-138.7%) | -$3.43 M(-35.0%) |
| Aug 2012 | - | -$835.80 K(-34.6%) | -$5.27 M(-38.9%) |
| May 2012 | - | -$1.28 M(-21.9%) | -$8.62 M(-35.5%) |
| Feb 2012 | - | -$1.64 M(+7.6%) | -$13.37 M(-22.2%) |
| Nov 2011 | -$17.16 M(-284.0%) | -$1.52 M(-63.7%) | -$17.18 M(-455.2%) |
| Aug 2011 | - | -$4.19 M(-30.5%) | $4.84 M(-18.3%) |
| May 2011 | - | -$6.03 M(+10.7%) | $5.92 M(-22.9%) |
| Feb 2011 | - | -$5.44 M(-126.6%) | $7.68 M(-17.2%) |
| Nov 2010 | $9.33 M | $20.49 M(-759.2%) | $9.27 M(-164.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2010 | - | -$3.11 M(-27.1%) | -$14.32 M(+129.1%) |
| May 2010 | - | -$4.26 M(+10.8%) | -$6.25 M(-12.2%) |
| Feb 2010 | - | -$3.85 M(+24.3%) | -$7.11 M(-41.1%) |
| Nov 2009 | -$13.73 M(-62.3%) | -$3.10 M(-162.4%) | -$12.08 M(-26.0%) |
| Aug 2009 | - | $4.96 M(-196.7%) | -$16.32 M(-49.3%) |
| May 2009 | - | -$5.13 M(-41.8%) | -$32.20 M(-17.4%) |
| Feb 2009 | - | -$8.82 M(+20.3%) | -$38.98 M(-6.3%) |
| Nov 2008 | -$36.41 M(+0.0%) | -$7.33 M(-32.9%) | -$41.60 M(-8.0%) |
| Aug 2008 | - | -$10.92 M(-8.2%) | -$45.24 M(+3.6%) |
| May 2008 | - | -$11.91 M(+4.1%) | -$43.66 M(+11.9%) |
| Feb 2008 | - | -$11.44 M(+4.2%) | -$39.02 M(+10.1%) |
| Nov 2007 | -$36.40 M(+67.4%) | -$10.97 M(+17.4%) | -$35.44 M(+18.9%) |
| Aug 2007 | - | -$9.35 M(+28.7%) | -$29.81 M(+11.3%) |
| May 2007 | - | -$7.26 M(-7.6%) | -$26.78 M(+7.4%) |
| Feb 2007 | - | -$7.86 M(+47.1%) | -$24.93 M(+15.3%) |
| Nov 2006 | -$21.74 M(+631.5%) | -$5.34 M(-15.3%) | -$21.62 M(+4.1%) |
| Aug 2006 | - | -$6.31 M(+16.6%) | -$20.77 M(+12.6%) |
| May 2006 | - | -$5.41 M(+18.8%) | -$18.45 M(+8.5%) |
| Feb 2006 | - | -$4.55 M(+1.5%) | -$17.00 M(+348.3%) |
| Nov 2005 | -$2.97 M(-83.6%) | -$4.49 M(+12.5%) | -$3.79 M(-13.1%) |
| Aug 2005 | - | -$3.99 M(+0.7%) | -$4.36 M(+26.3%) |
| May 2005 | - | -$3.96 M(-145.8%) | -$3.46 M(-25.6%) |
| Feb 2005 | - | $8.65 M(-270.9%) | -$4.64 M(-74.6%) |
| Nov 2004 | -$18.16 M(+4.6%) | -$5.06 M(+64.3%) | -$18.32 M(-3.3%) |
| Aug 2004 | - | -$3.08 M(-40.2%) | -$18.94 M(-6.6%) |
| May 2004 | - | -$5.15 M(+2.6%) | -$20.28 M(+5.5%) |
| Feb 2004 | - | -$5.02 M(-11.7%) | -$19.21 M(+10.5%) |
| Nov 2003 | -$17.36 M(+21.8%) | -$5.69 M(+28.8%) | -$17.38 M(+4.6%) |
| Aug 2003 | - | -$4.41 M(+8.0%) | -$16.61 M(+4.6%) |
| May 2003 | - | -$4.09 M(+28.2%) | -$15.88 M(+1.4%) |
| Feb 2003 | - | -$3.19 M(-35.2%) | -$15.65 M(-8.5%) |
| Nov 2002 | -$14.25 M(+74.4%) | -$4.92 M(+33.4%) | -$17.11 M(+34.1%) |
| Aug 2002 | - | -$3.69 M(-4.5%) | -$12.76 M(+5.1%) |
| May 2002 | - | -$3.86 M(-16.9%) | -$12.14 M(+15.0%) |
| Feb 2002 | - | -$4.65 M(+726.5%) | -$10.55 M(+30.1%) |
| Nov 2001 | -$8.18 M(+33.6%) | -$562.50 K(-81.6%) | -$8.11 M(-14.3%) |
| Aug 2001 | - | -$3.06 M(+34.7%) | -$9.46 M(+23.0%) |
| May 2001 | - | -$2.27 M(+3.1%) | -$7.69 M(+9.6%) |
| Feb 2001 | - | -$2.21 M(+15.3%) | -$7.02 M(+16.0%) |
| Nov 2000 | -$6.12 M(+60.9%) | -$1.91 M(+48.2%) | -$6.05 M(+13.5%) |
| Aug 2000 | - | -$1.29 M(-19.4%) | -$5.33 M(+7.1%) |
| May 2000 | - | -$1.60 M(+29.1%) | -$4.97 M(+13.3%) |
| Feb 2000 | - | -$1.24 M(+3.9%) | -$4.39 M(+11.3%) |
| Nov 1999 | -$3.80 M(+2.5%) | -$1.19 M(+27.4%) | -$3.94 M(+7.3%) |
| Aug 1999 | - | -$936.70 K(-7.9%) | -$3.68 M(-2.0%) |
| May 1999 | - | -$1.02 M(+27.9%) | -$3.75 M(-5.5%) |
| Feb 1999 | - | -$795.50 K(-14.2%) | -$3.97 M(-6.1%) |
| Nov 1998 | -$3.71 M(-13.4%) | -$926.80 K(-8.5%) | -$4.23 M(+4.1%) |
| Aug 1998 | - | -$1.01 M(-18.1%) | -$4.06 M(-1.6%) |
| May 1998 | - | -$1.24 M(+17.2%) | -$4.13 M(-3.3%) |
| Feb 1998 | - | -$1.05 M(+38.9%) | -$4.27 M(+0.7%) |
| Nov 1997 | -$4.29 M(+9.0%) | -$759.00 K(-29.7%) | -$4.24 M(+21.8%) |
| Aug 1997 | - | -$1.08 M(-21.7%) | -$3.48 M(+45.0%) |
| May 1997 | - | -$1.38 M(+34.8%) | -$2.40 M(+134.8%) |
| Feb 1997 | - | -$1.02 M | -$1.02 M |
| Nov 1996 | -$3.93 M | - | - |
FAQ
- What is Theratechnologies annual EBITDA?
- What is the all time high annual EBITDA for Theratechnologies?
- What is Theratechnologies annual EBITDA year-on-year change?
- What is Theratechnologies quarterly EBITDA?
- What is the all time high quarterly EBITDA for Theratechnologies?
- What is Theratechnologies quarterly EBITDA year-on-year change?
- What is Theratechnologies TTM EBITDA?
- What is the all time high TTM EBITDA for Theratechnologies?
- What is Theratechnologies TTM EBITDA year-on-year change?
What is Theratechnologies annual EBITDA?
The current annual EBITDA of THTX is -$9.86 M
What is the all time high annual EBITDA for Theratechnologies?
Theratechnologies all-time high annual EBITDA is $9.33 M
What is Theratechnologies annual EBITDA year-on-year change?
Over the past year, THTX annual EBITDA has changed by +$17.97 M (+64.57%)
What is Theratechnologies quarterly EBITDA?
The current quarterly EBITDA of THTX is $7.00 M
What is the all time high quarterly EBITDA for Theratechnologies?
Theratechnologies all-time high quarterly EBITDA is $20.49 M
What is Theratechnologies quarterly EBITDA year-on-year change?
Over the past year, THTX quarterly EBITDA has changed by +$4.00 M (+133.86%)
What is Theratechnologies TTM EBITDA?
The current TTM EBITDA of THTX is $11.56 M
What is the all time high TTM EBITDA for Theratechnologies?
Theratechnologies all-time high TTM EBITDA is $11.56 M
What is Theratechnologies TTM EBITDA year-on-year change?
Over the past year, THTX TTM EBITDA has changed by +$26.74 M (+176.20%)